Tissue Regenix Group PLC (LON:TRX) has completed phase one of the expansion of its manufacturing facility in San Antonio, Texas.
The regenerative medical devices company has expanded the space for supporting administrative departments and built and qualified two additional clean rooms. The two clean rooms are being used to process and pack tissue products, bringing the company's total number of clean rooms to seven.
Relocation of the supporting departments to the adjacent facility has also created additional expansion opportunities for production and quality functions in the company's existing facility, Tissue Regenix said.
"The completion of our phase one expansion plans on time and on budget is excellent news and provides us additional capacity and flexibility in line with our projected growth in our different target markets. Staging our expansion was a prudent opportunity to meet our demand and capacity needs in an efficient manner,” said Daniel Lee, the chief executive officer of Tissue Regenix.
#TRX #TissueRegenix Nice to see their Phase 1 expansion plan complete this morning.
Quite a lot of director buys recently, so at some point this should have a good run I expect.
— The Masked Stock Trader (@ProAIMTrader) June 28, 2021